{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-22-003841","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2022-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.391251+00:00","generated_at":"2026-06-22T05:28:28.572152+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ReWalk Q3 revenue down 63% to $0.9M, loss widens; submits first Medicare case for coverage","bullets":["Q3 revenue $0.9M, down 63% YoY from $2.0M; net loss widened to $5.5M from $2.7M.","Gross margin fell to 25% from 58% due to lower personal device sales and higher costs.","Submitted first Medicare case to MAC for exoskeleton coverage; German court hearing Nov 10.","Cash $74.0M, no debt; $0.9M in share repurchases since program initiation."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-22-003841","json":"https://secwatch.observer/filing/0001178913-22-003841.json","markdown":"https://secwatch.observer/filing/0001178913-22-003841.md","text":"https://secwatch.observer/filing/0001178913-22-003841.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891322003841/0001178913-22-003841-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891322003841/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T05:28:28.572152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"af0f673e89bfd303020665f5d7b28303095510c0","claim":"Lifeward Ltd. reported the third quarter ended September 30, 2022 results: revenue $0.9 million, net income $5.5 million dollars.","evidence_excerpt":"to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries As of November 4 th , ReWalk Has Repurchased $0.9 Million of Common Stock Since Initiation of Its Program German Federal Social Court Hearing on November 10 th with Ruling Expected Shortly After MARLBOROUGH, Mass. BERLIN, Germany and","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891322003841/0001178913-22-003841-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$0.9 million"},{"label":"Net income","value":"$5.5 million dollars"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}